United States Imatinib Drugs Market Report 2017

December 2017 | 104 pages | ID: U303DA064E4EN
QYResearch

Abstracts

In this report, the United States Imatinib Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Imatinib Drugs in these regions, from 2012 to 2022 (forecast).

United States Imatinib Drugs market competition by top manufacturers/players, with Imatinib Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Apotex Inc.
• Novartis
• Sanofi S.A.
• Cipla Inc.
• Mylan Pharms Inc.
• Glenmark Pharmaceuticals Ltd.
• Sun Pharmaceuticals
• Actavis Generics
• Dr. Reddy's Laboratories
• Teva Pharmaceutical Industries Ltd.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Capsules
• Tablets

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Drug Stores
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Imatinib Drugs Market Report 2017

1 IMATINIB DRUGS OVERVIEW

1.1 Product Overview and Scope of Imatinib Drugs
1.2 Classification of Imatinib Drugs by Product Category
  1.2.1 United States Imatinib Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Imatinib Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Capsules
  1.2.4 Tablets
1.3 United States Imatinib Drugs Market by Application/End Users
  1.3.1 United States Imatinib Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Drug Stores
  1.3.4 Other
1.4 United States Imatinib Drugs Market by Region
  1.4.1 United States Imatinib Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Imatinib Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Imatinib Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Imatinib Drugs Status and Prospect (2012-2022)
  1.4.5 New England Imatinib Drugs Status and Prospect (2012-2022)
  1.4.6 The South Imatinib Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Imatinib Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Imatinib Drugs (2012-2022)
  1.5.1 United States Imatinib Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Imatinib Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES IMATINIB DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Imatinib Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Imatinib Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Imatinib Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Imatinib Drugs Market Competitive Situation and Trends
  2.4.1 United States Imatinib Drugs Market Concentration Rate
  2.4.2 United States Imatinib Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Imatinib Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES IMATINIB DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Imatinib Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Imatinib Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Imatinib Drugs Price by Region (2012-2017)

4 UNITED STATES IMATINIB DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Imatinib Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Imatinib Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Imatinib Drugs Price by Type (2012-2017)
4.4 United States Imatinib Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES IMATINIB DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Imatinib Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Imatinib Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES IMATINIB DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Apotex Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Imatinib Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Apotex Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis
  6.2.2 Imatinib Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi S.A.
  6.3.2 Imatinib Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi S.A. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Cipla Inc.
  6.4.2 Imatinib Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Cipla Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Mylan Pharms Inc.
  6.5.2 Imatinib Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Mylan Pharms Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Glenmark Pharmaceuticals Ltd.
  6.6.2 Imatinib Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sun Pharmaceuticals
  6.7.2 Imatinib Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sun Pharmaceuticals Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Actavis Generics
  6.8.2 Imatinib Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Actavis Generics Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Dr. Reddy's Laboratories
  6.9.2 Imatinib Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Dr. Reddy's Laboratories Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Teva Pharmaceutical Industries Ltd.
  6.10.2 Imatinib Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 IMATINIB DRUGS MANUFACTURING COST ANALYSIS

7.1 Imatinib Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Imatinib Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Imatinib Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Imatinib Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES IMATINIB DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Imatinib Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Imatinib Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Imatinib Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Imatinib Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Imatinib Drugs
Figure United States Imatinib Drugs Market Size (MT) by Type (2012-2022)
Figure United States Imatinib Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Capsules Product Picture
Figure Tablets Product Picture
Figure United States Imatinib Drugs Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Imatinib Drugs by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Drug Stores Examples
Table Key Downstream Customer in Drug Stores
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Imatinib Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Imatinib Drugs Sales (MT) and Growth Rate (2012-2022)
Figure United States Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Imatinib Drugs Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Imatinib Drugs Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Imatinib Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Imatinib Drugs Sales Share by Players/Suppliers
Figure 2017 United States Imatinib Drugs Sales Share by Players/Suppliers
Figure United States Imatinib Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Imatinib Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Imatinib Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Imatinib Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Imatinib Drugs Revenue Share by Players/Suppliers
Table United States Market Imatinib Drugs Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Imatinib Drugs Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Imatinib Drugs Market Share of Top 3 Players/Suppliers
Figure United States Imatinib Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Imatinib Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Imatinib Drugs Product Category
Table United States Imatinib Drugs Sales (MT) by Region (2012-2017)
Table United States Imatinib Drugs Sales Share by Region (2012-2017)
Figure United States Imatinib Drugs Sales Share by Region (2012-2017)
Figure United States Imatinib Drugs Sales Market Share by Region in 2016
Table United States Imatinib Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Imatinib Drugs Revenue Share by Region (2012-2017)
Figure United States Imatinib Drugs Revenue Market Share by Region (2012-2017)
Figure United States Imatinib Drugs Revenue Market Share by Region in 2016
Table United States Imatinib Drugs Price (USD/Kg) by Region (2012-2017)
Table United States Imatinib Drugs Sales (MT) by Type (2012-2017)
Table United States Imatinib Drugs Sales Share by Type (2012-2017)
Figure United States Imatinib Drugs Sales Share by Type (2012-2017)
Figure United States Imatinib Drugs Sales Market Share by Type in 2016
Table United States Imatinib Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Imatinib Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Imatinib Drugs by Type (2012-2017)
Figure Revenue Market Share of Imatinib Drugs by Type in 2016
Table United States Imatinib Drugs Price (USD/Kg) by Types (2012-2017)
Figure United States Imatinib Drugs Sales Growth Rate by Type (2012-2017)
Table United States Imatinib Drugs Sales (MT) by Application (2012-2017)
Table United States Imatinib Drugs Sales Market Share by Application (2012-2017)
Figure United States Imatinib Drugs Sales Market Share by Application (2012-2017)
Figure United States Imatinib Drugs Sales Market Share by Application in 2016
Table United States Imatinib Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Imatinib Drugs Sales Growth Rate by Application (2012-2017)
Table Apotex Inc. Basic Information List
Table Apotex Inc. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Apotex Inc. Imatinib Drugs Sales Growth Rate (2012-2017)
Figure Apotex Inc. Imatinib Drugs Sales Market Share in United States (2012-2017)
Figure Apotex Inc. Imatinib Drugs Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis Imatinib Drugs Sales Growth Rate (2012-2017)
Figure Novartis Imatinib Drugs Sales Market Share in United States (2012-2017)
Figure Novartis Imatinib Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi S.A. Basic Information List
Table Sanofi S.A. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi S.A. Imatinib Drugs Sales Growth Rate (2012-2017)
Figure Sanofi S.A. Imatinib Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi S.A. Imatinib Drugs Revenue Market Share in United States (2012-2017)
Table Cipla Inc. Basic Information List
Table Cipla Inc. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Cipla Inc. Imatinib Drugs Sales Growth Rate (2012-2017)
Figure Cipla Inc. Imatinib Drugs Sales Market Share in United States (2012-2017)
Figure Cipla Inc. Imatinib Drugs Revenue Market Share in United States (2012-2017)
Table Mylan Pharms Inc. Basic Information List
Table Mylan Pharms Inc. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Mylan Pharms Inc. Imatinib Drugs Sales Growth Rate (2012-2017)
Figure Mylan Pharms Inc. Imatinib Drugs Sales Market Share in United States (2012-2017)
Figure Mylan Pharms Inc. Imatinib Drugs Revenue Market Share in United States (2012-2017)
Table Glenmark Pharmaceuticals Ltd. Basic Information List
Table Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales Growth Rate (2012-2017)
Figure Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales Market Share in United States (2012-2017)
Figure Glenmark Pharmaceuticals Ltd. Imatinib Drugs Revenue Market Share in United States (2012-2017)
Table Sun Pharmaceuticals Basic Information List
Table Sun Pharmaceuticals Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sun Pharmaceuticals Imatinib Drugs Sales Growth Rate (2012-2017)
Figure Sun Pharmaceuticals Imatinib Drugs Sales Market Share in United States (2012-2017)
Figure Sun Pharmaceuticals Imatinib Drugs Revenue Market Share in United States (2012-2017)
Table Actavis Generics Basic Information List
Table Actavis Generics Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Actavis Generics Imatinib Drugs Sales Growth Rate (2012-2017)
Figure Actavis Generics Imatinib Drugs Sales Market Share in United States (2012-2017)
Figure Actavis Generics Imatinib Drugs Revenue Market Share in United States (2012-2017)
Table Dr. Reddy's Laboratories Basic Information List
Table Dr. Reddy's Laboratories Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Dr. Reddy's Laboratories Imatinib Drugs Sales Growth Rate (2012-2017)
Figure Dr. Reddy's Laboratories Imatinib Drugs Sales Market Share in United States (2012-2017)
Figure Dr. Reddy's Laboratories Imatinib Drugs Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Industries Ltd. Basic Information List
Table Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Imatinib Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Imatinib Drugs
Figure Manufacturing Process Analysis of Imatinib Drugs
Figure Imatinib Drugs Industrial Chain Analysis
Table Raw Materials Sources of Imatinib Drugs Major Players/Suppliers in 2016
Table Major Buyers of Imatinib Drugs
Table Distributors/Traders List
Figure United States Imatinib Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Imatinib Drugs Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Imatinib Drugs Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Imatinib Drugs Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Imatinib Drugs Sales Volume (MT) Forecast by Type in 2022
Table United States Imatinib Drugs Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Imatinib Drugs Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Imatinib Drugs Sales Volume (MT) Forecast by Application in 2022
Table United States Imatinib Drugs Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Imatinib Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Imatinib Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Imatinib Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources